Serum high-density lipoprotein cholesterol levels and mortality in frail, community-living elderly

Gerontology

Volumn 54, Issue 2, 2008, Pages 71-78

  Landi, Francesco ^a   Russo, Andrea ^a   Pahor, Marco ^b,c   Capoluongo, Ettore ^a   Liperoti, Rosa ^a   Cesari, Matteo ^a   Bernabei, Roberto ^a   Onder, Graziano ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Frail community living elderly; High density lipoprotein cholesterol; Mortality, frail elderly

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

AGED; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; COMMUNITY CARE; COMMUNITY LIVING; CONTROLLED STUDY; DAILY LIFE ACTIVITY; ELDERLY CARE; FEMALE; FOLLOW UP; FRAIL ELDERLY; HAZARD RATIO; HUMAN; LIPOPROTEIN METABOLISM; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIMARY HEALTH CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RISK ASSESSMENT; SCORING SYSTEM; SURVIVAL TIME;

AGED, 80 AND OVER; CHOLESTEROL, HDL; COHORT STUDIES; FEMALE; FRAIL ELDERLY; HUMANS; MALE; MORTALITY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; TRIGLYCERIDES;

EID: 43449129740     PISSN: 0304324X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000111381     Document Type: Article

References (40)

1. Zuliani G, Romagnoli F, Bollini C, Leoci V, Soattin L, Fellin R: Low Levels of high-density lipoprotein cholesterol are a marker of disability in the elderly. Gerontology 1999;45:317-322.
2. Bosy-Westphal A, Geisler C, Onur S, Korth O, Selberg O, Schrezenmeir J, Müller MJ: Value of body fat mass vs anthropometric obesity indices in the assessment of metabolic risk factors. Int J Obes (Lond) 2006;30:475-483.
3. Mazza A, Zamboni S, Tikhonoff V, Schiavon L, Pessina AC, Caviglia E: Body mass index and mortality in elderly men and women from general population. The experience of Cardiovascular Study in the Elderly (CASTEL). Gerontology 2007;53:36-45.
4. Schubert CM, Rogers NL, Remsberg KE, Sun SS, Chumlea WC, Demerath EW, Czerwinski SA, Towne B, Siervogel RM: Lipids, lipoproteins, lifestyle, adiposity and fat-free mass during middle age: the Fels Longitudinal Study. Int J Obes (Lond) 2006;30:251-260.
5. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R: Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005;366:1267-1278.
6. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH: The disease burden associated with overweight and obesity. JAMA 1999;282:1523-1529.
7. Anderson KM, Castelli WP, Levy D: Cholesterol and mortality: 30 years of follow-up from the Framingham Study. JAMA 1987;257:2176-2180.
8. Staessen J, Amery A, Birkenhager W, et al: Is a high serum cholesterol level associated with longer survival in elderly hypertensives? J Hypertens 1990;8:755-761.
9. Schatz IJ, Masaki K, Yano K, Chen R, Rodriguez BL, Curb JD: Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study. Lancet 2001;358:351-355.
10. Weverling-Rijnsburger AW, Blauw GJ, Lagaay AM, Knook DL, Meinders AE, Westendorp RG: Total cholesterol and risk of mortality in the oldest old. Lancet 1997;350:1119-1123.
11. Corti MC, Guralnik JM, Salive ME, Harris T, Ferrucci L, Glynn RJ, Havlik RJ: Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons. Ann Intern Med 1997;126:753-760.
12. Jacobs DR Jr: Why is low blood cholesterol associated with risk of nonatherosclerotic disease death? Annu Rev Public Health 1993;14:95-114.
13. Toth PP: High-density lipoprotein as a therapeutic target: clinical evidence and treatment strategies. Am J Cardiol 2005;96:50-58.
14. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, Jacobs DR Jr, Bangdiwala S, Tyroler HA: High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989;79:8-15.
15. Rywik SL, Manolio TA, Pajak A, Piotrowski W, Davis CE, Broda GB, Kawalec E: Association of lipids and lipoprotein level with total mortality and mortality caused by cardiovascular and cancer diseases (Poland and United States collaborative study on cardiovascular epidemiology). Am J Cardiol 1999;84:540-548.
16. Perova NV, Oganov RG, Williams DH, Irving SH, Abernathy JR, Deev AD, Shestov DB, Zhukovsky GS, Davis CE, Tyroler HA: Association of high-density-lipoprotein cholesterol with mortality and other risk factors for major chronic noncommunicable diseases in samples of US and Russian men. Ann Epidemiol 1995;5:179-185.
17. Stensvold I, Urdal P, Thurmer H, Tverdal A, Lund-Larsen PG, Foss OP: High-density-lipoprotein cholesterol and coronary, cardiovascular and all-cause mortality among middle-aged Norwegian men and women. Eur Heart J 1992;13:1155-1163.
18. Paunio M, Heinonen OP, Virtamo J, Klag MJ, Manninen V, Albanes D, Comstock GW: HDL cholesterol and mortality in Finnish men with special reference to alcohol intake. Circulation 1994;90:2909-2918.
19. Landi F, Russo A, Cesari M, Barillaro C, Onder G, Zamboni V, De Santis A, Pahor M, Ferrucci L, Bernabei R: The ilSIRENTE study: a prospective cohort study on persons aged 80 years and older living in a mountain community of Central Italy. Aging Clin Exp Res 2005;17:486-493.
20. Morris JN, Fries BE, Meher DR: MDS Cognitive Performance Scale. J Gerontol 1994;49:M174-M182.
21. Morris JN, Fries BE, Bernabei R, Ikegami N, Gilgen R, Steel K: RAI - Home Care Assessment Manual. Washington, InterRAI, 1996.
22. Morris JN, Fries BE, Steel K, Ikegami N, Bernabei R, Carpenter GI, Gilgen R, Hirdes JP, Topinkova E: Comprehensive clinical assessment in community setting: applicability of the MDS-HC. J Am Geriatr Soc 1997;45:1017-1024.
23. Landi F, Tua E, Onder G, Carrara B, Sgadari A, Rinaldi C, Gambassi G, Lattanzio F, Bernabei R;SILVERNET-HC Study Group of Bergamo: Minimum data set for home care: a valid instrument to assess frail older people living in the community. Med Care 2000;38:1184-1190.
24. Ferrucci L, Bandinelli S, Benvenuti E, Di Iorio A, Macchi C, Harris TB: Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI study. J Am Geriatr Soc 2000;48:1618-1625.
25. Onder G, Landi F, Volpato S, Fellin R, Carbonin PU, Gambassi G, Bernabei R: Serum cholesterol levels and in-hospital mortality in the elderly. Am J Med 2003;115:265-271.
26. Norrish A, North D, Yee RL, Jackson R: Do cardiovascular disease risk factors predict all-cause mortality? Int J Epidemiol 1995;24:908-914.
27. Landi F, Onder G, Gambassi G, Pedone C, Carbonin P, Bernabei R: Body mass index and mortality among hospitalized patients. Arch Intern Med 2000;160:2641-2644.
28. Choinière R, Lafontaine P, Edwards AC: Distribution of cardiovascular disease risk factors by socioeconomic status among Canadian adults. CMAJ 2000;162:13-24.
29. Iribarren C, Jacobs DR Jr, Sidney S, Claxton AJ, Feingold KR: Cohort study of serum total cholesterol and in-hospital incidence of infectious diseases. Epidemiol Infect 1998;121:335-347.
30. Dyker AG, Weir CJ, Lees KR: Influence of cholesterol on survival after stroke: retrospective study. BMJ 1997;314:1584-1588.
31. Delgado-Rodríguez M, Medina-Cuadros M, Gómez-Ortega A, Martínez-Gallego G, Mariscal-Ortiz M, Martínez-Gonzalez MA, Sillero-Arenas M: Cholesterol and serum albumin levels as predictors of cross infection, death, and length of hospital stay. Arch Surg 2002;137:805-812.
32. Becker RC, Corrao JM, Lew R, Bradley J, Queenan J: Relationship between serum total cholesterol, infarct size, and early clinical outcome following acute myocardial infarction. Cardiology 1992;80:65-70.
33. Manolio TA, Ettinger WH, Tracy RP, Kuller LH, Borhani NO, Lynch JC, Fried LP: Epidemiology of low cholesterol levels in older adults. The Cardiovascular Health Study. Circulation 1993;87:728-737.
34. Onder G, Volpato S, Liperoti R, D'Arco C, Maraldi C, Fellin R, Bernabei R, Landi F; GIFA Investigators: Total serum cholesterol and recovery from disability among hospitalized older adults. J Gerontol A Biol Sci Med Sci 2006;61:736-742.
35. Wallace RB, Colsher PL: Blood lipid distributions in older persons. Prevalence and correlates of hyperlipidemia. Ann Epidemiol 1992;2:15-21.
36. Nikkila M, Heikkinen J: High-density lipoprotein cholesterol and longevity. Age Ageing 1990;19:119-124.
37. Brophy JM, Bourgault C, Brassard P: The use of cholesterol-lowering medications after coronary revascularization. CMAJ 2003;169:1153-1157.
38. Kontush A, de Faria EC, Chantepie S, Chapman MJ: A normotriglyceridemic, low HDL-cholesterol phenotype is characterised by elevated oxidative stress and HDL particles with attenuated antioxidative activity. Atherosclerosis 2005;182:277-285.
39. Brewer HB Jr, Santamarina-Fojo S: Clinical significance of high-density lipoproteins and the development of atherosclerosis: focus on the role of the adenosine triphosphate-binding cassette protein A1 transporter. Am J Cardiol 2003;92(4B):10K-16K.
40. Barnett E, Anderson T, Blosnich J, Halverson J, Novak J: Promoting cardiovascular health: from individual goals to social environmental change. Am J Prev Med 2005;29(5 Suppl 1):107-112.